Kingstone Capital Partners Texas LLC Invests $155.19 Million in CVS Health Corporation $CVS

Key Points

• Kingstone Capital Partners Texas LLC acquired 2,145,239 shares of CVS Health Corporation, valued at approximately $155.2 million, representing a 0.17% ownership stake as of the latest SEC filing.
• CVS Health reported $1.81 earnings per share (EPS) for the last quarter, exceeding the consensus estimate by $0.35, with total revenue reaching $98.92 billion.
• The company announced a quarterly dividend of $0.665 per share to be paid on November 3rd, with a 3.5% dividend yield based on its annualized dividend payout.

Kingstone Capital Partners Texas LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 2,145,239 shares of the pharmacy operator's stock, valued at approximately $155,185,000. Kingstone Capital Partners Texas LLC owned about 0.17% of CVS Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CVS. Essex Financial Services Inc. raised its holdings in shares of CVS Health by 0.8% in the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock valued at $1,403,000 after buying an additional 166 shares during the last quarter. Hemington Wealth Management lifted its stake in shares of CVS Health by 33.7% during the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock valued at $46,000 after buying an additional 172 shares during the period. Sumitomo Life Insurance Co. raised its stake in CVS Health by 1.0% during the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after purchasing an additional 174 shares during the period. Koshinski Asset Management Inc. raised its stake in CVS Health by 3.7% during the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock worth $334,000 after purchasing an additional 178 shares during the period. Finally, Horizon Bancorp Inc. IN raised its stake in CVS Health by 7.4% during the first quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock worth $177,000 after purchasing an additional 180 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

NYSE CVS traded up $0.53 during trading on Friday, hitting $74.95. 13,414,318 shares of the company's stock were exchanged, compared to its average volume of 6,679,727. The company has a market cap of $95.06 billion, a PE ratio of 20.94, a P/E/G ratio of 0.83 and a beta of 0.62. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average price is $67.91 and its two-hundred day moving average price is $66.63. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $76.24.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company's revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.22% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on CVS shares. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $67.00 to $79.00 in a research report on Monday, August 18th. Zacks Research downgraded shares of CVS Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 8th. Sanford C. Bernstein lifted their price objective on shares of CVS Health from $72.00 to $77.00 and gave the stock a "market perform" rating in a research note on Friday, September 5th. Barclays lifted their target price on shares of CVS Health from $80.00 to $87.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Finally, Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Sunday. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $77.89.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.